About Us
Telix Pharmaceuticals was created to deliver on the promise of nuclear medicine
The field of nuclear medicine has historically lacked clinical momentum and commitment to late-stage product development. Our goal is to rectify this for the benefit of patients.
)
Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited, to speak at Jefferies 2019 London Healthcare Conference
LONDON (United Kingdom) – November 19, 2019 – Dr. Christian Behrenbruch, CEO of Telix Pharmaceuticals Limited, to speak at Jefferies...
Telix Pharmaceuticals Program Update Q3 2019
MELBOURNE (Australia) – Nov. 4, 2019 - Telix Pharmaceuticals Ltd Program Update Q3, 2019
Telix Pharmaceuticals to Acquire European Production Facility
MELBOURNE (Australia) and BRUSSELS (Belgium) – Oct. 3, 2019 - Telix Pharmaceuticals Ltd is pleased to announce that it has...
Telix Cleared to Commence Renal Cancer Imaging Study in Japan
Melbourne (Australia) and Kyoto (Japan) – 30 August 2019. Telix Pharmaceuticals Limited today announced the completion of a Clinical Trial...